[Investigation of antihypoxic properties of short peptides].
Kozina. L S LS
Key Findings
- Short regulatory peptides showed antihypoxic effects in a hypobaric hypoxia model.
- Pinealon (Glu-Asp-Arg) had the strongest protective effect among the tested peptides.
- The protective effect appears to involve stimulation of internal antioxidant enzymes and possibly reducing NMDA‑mediated excitotoxicity.
Practical Outcomes
- For now, the results are mostly pre‑clinical, so there’s no clear dosage or protocol for humans. Biohackers might watch for future human trials, especially with pinealon, but using vilon for hypoxia protection remains speculative.
Summary
The study found that a few short peptides, including vilon, epitalon, vesugen, and especially pinealon, can help protect cells from low‑oxygen stress in animal experiments. Pinealon worked best, likely by boosting the body's own antioxidant enzymes rather than just blocking harmful free radicals.
Abstract
The data presented suggest that short regulatory peptides (vilon, epitalon, vesugen and pinealon) have manifested the antihypoxic properties in the model of hypobaric hypoxia. Pinealon (Glu-Asp-Arg) has the most pronounced effect among them. The capability of pinealon to increase the neuronal resistance to hypoxic stress in experiments with prenatal hypoxia has a complex nature. It is based not so much on the inhibition of ROS increase in cells in response to stress as on stimulation of internal antioxidative enzyme system and possibly limiting the excitotoxic effect of N-methyl-D-aspartate.
Study Information
pubmed
2008